Improving companies’ access to Flemingsberg’s research infrastructure

Work continues to strengthen collaboration between small and medium-sized enterprises and the research infrastructures in Flemingsberg. Flemingsberg Science leads this project together with Karolinska Institutet and the Center for Innovative Medicine (CIMED).

Campus Flemingsberg has approximately 20 research infrastructures that support high-tech basic research and conventional research. Cutting-edge expertise in areas such as imaging, bioinformatics, cell therapy and movement analysis is included. More of these research infrastructures will now also be able to offer their services to small and medium-sized companies.

“Our research infrastructures are a key part of Campus Flemingsberg. Now we want to give more infrastructures the opportunity to collaborate with companies in the Life Science sector,” says Johnny Högberg, CEO Flemingsberg Science.

Following up Stockholm Life Tech
In a new project, Flemingsberg Science is collaborating with Karolinska Institutet and CIMED. The project follows up on the experiences of the Stockholm Life Tech project, which identified considerable potential to strengthen research infrastructures and companies on Campus Flemingsberg. Within the framework of Stockholm Life Tech, among other things, a guide was developed that functions as a support through the entire process from preparation, development to execution.

“The methodology that was developed can be used to improve how the infrastructures function, for example by providing them with a broader basis for their funding. We aim to add one or two research infrastructures a year to 2025,” says Högberg.

CIMED is a regional research fund tasked with stimulating research and enriching the research environment at Campus Flemingsberg.

“The presence of different kinds of companies, including startups, enriches and develops the campus environment. Strong collaboration between companies, universities and healthcare is crucial for us to further improve the research environment,” explains Annika Bergquist, Director CIMED.

The project is planned to continue until 2025 and will be evaluated annually.
“We always work with smaller pilot projects, “test balloons” as they’re called, and can provide temporary stimulus funds. If the project works well, the plan is to continue to develop it without support,” says Bergquist.

South Korean Game Investors Visited Press Start Game Hub in Flemingsberg

A delegation of investors from some of South Korea’s leading game companies visited Press Start Game Hub in Flemingsberg yesterday, a growing hub for game innovation and entrepreneurship in Europe. The visit was part of an initiative organized by Business Sweden, aimed at strengthening ties between the Swedish and South Korean gaming industries.

The Flemingsberg Science Foundation welcomes Angela Hoyer as the new Networks and Event Manager

With a background as a researcher at Karolinska Institutet and experience from academia, industry, and networking, Angela Hoyer, the new Networks and Event Manager at the Flemingsberg Science Foundation, is passionate about developing the life science sector. In her new role, Angela looks forward to creating meeting places where collaborations can grow, while also contributing to Flemingsberg’s continued development as a strong international hub for research and innovation.

A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated

With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.